Gait in Multiple Sclerosis Improved With Dalfampridine Plus Physical Therapy
A combination of dalfampridine extended-release and physical therapy (PT) has shown efficacy for improving gait in people with multiple sclerosis
CMSC 2018
Multiple Sclerosis Pain Common Disruptive Factor in Everyday Activities
Pain in patients with multiple sclerosis may affect their daily functioning regardless of disease severity.
Dimethyl Fumarate Not Associated With Greater Pain vs Other DMTs in Relapsing-Remitting MS
Investigators assessed the effect of disease-modifying treatments on pain in patients with relapsing-remitting multiple sclerosis.
Medical Cannabis Shows Promise in Treating Symptoms of Multiple Sclerosis
Differing formulations and ratios of the subjects’ medical cannabis regimens have been accounted for, though further information about ratios of CBD and TCH are subject to change due to continued ongoing research.
Skin Tone, Race May Be Associated With Multiple Sclerosis Diagnosis
The MS and monophasic ADS groups were compared using quantified melanin measurements via the DSM II Colorimeter; self-reported skin tones of fair, medium, olive, or dark; a self-reported race; and skin tone, which was self-reported using 10 numerical panels of color.
Proposed Protocol Taps Occupational Therapist for Assistance With MS Medication Adherence
The protocol authors propose a more objective method of managing medication adherence through a profile performed by an occupational therapist.
Optimized Urinalysis Reflex Reduces Urine Culture Orders in MS
Due to the increased risk for urinary tract infections (UTIs) in people with MS and similar CNS demyelinating diseases, as well as the tendency of UTIs to trigger more MS flares, the affected population are subject to a large number of unneeded antibiotic prescriptions and asymptomatic bacteriuria treatments.
Certain Comorbidities More Common in People With Multiple Sclerosis
The study researchers examined data from the US database of the IMS Health Real World Data Adjudicated Claims between 2011 and 2015.
Tuberculosis Common in MS Treated With Immunosuppressive Agents
Immunotherapy in multiple sclerosis may increase the risk for conversion from latent to active tuberculosis infection.
Ozanimod Superior to Interferon for Relapsing Multiple Sclerosis
This study analyzed results from SUNBEAM (ClinicalTrials.gov Identifier: NCT02294058) and RADIANCE (ClinicalTrials.gov Identifier: NCT01628393), 2 double-blind, randomized, phase 3 trials.
Next post in CMSC 2018
